These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15725191)

  • 1. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance.
    Jakobsen CG; Bodtger U; Poulsen LK; Roggen EL
    Clin Exp Allergy; 2005 Feb; 35(2):193-8. PubMed ID: 15725191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
    Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
    Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v 1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to Fc epsilon RI.
    Purohit A; Laffer S; Metz-Favre C; Verot A; Kricek F; Valenta R; Pauli G
    Clin Exp Allergy; 2005 Feb; 35(2):186-92. PubMed ID: 15725190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food allergy to apple and specific immunotherapy with birch pollen.
    Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
    Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy.
    van Neerven RJ; Knol EF; Ejrnaes A; Würtzen PA
    Int Arch Allergy Immunol; 2006; 141(2):119-29. PubMed ID: 16864979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.
    Focke M; Linhart B; Hartl A; Wiedermann U; Sperr WR; Valent P; Thalhamer J; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Oct; 34(10):1525-33. PubMed ID: 15479266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is immunotherapy-induced birch-pollen-specific IgG4 a marker for decreased allergen-specific sensitivity?
    Bodtger U; Ejrnaes AM; Hummelshoj L; Jacobi HH; Poulsen LK; Svenson M
    Int Arch Allergy Immunol; 2005 Apr; 136(4):340-6. PubMed ID: 15741732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity.
    Reisinger J; Horak F; Pauli G; van Hage M; Cromwell O; König F; Valenta R; Niederberger V
    J Allergy Clin Immunol; 2005 Aug; 116(2):347-54. PubMed ID: 16083789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK; Francis JN; Durham SR
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response.
    Svirshchevskaya EV; Viskova N; Shevchenko M; Alekseeva L; Marchenko A; Benevolensky S; Kurup VP
    Med Sci Monit; 2004 Oct; 10(10):BR371-80. PubMed ID: 15448590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy.
    Lalek N; Kosnik M; Silar M; Korosec P
    Clin Exp Allergy; 2010 Aug; 40(8):1186-93. PubMed ID: 20528883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity determinations of purified IgE and IgG antibodies against the major pollen allergens Phl p 5a and Bet v 1a: discrepancy between IgE and IgG binding strength.
    Hantusch B; Schöll I; Harwanegg C; Krieger S; Becker WM; Spitzauer S; Boltz-Nitulescu G; Jensen-Jarolim E
    Immunol Lett; 2005 Feb; 97(1):81-9. PubMed ID: 15626479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
    Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
    Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
    Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
    Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased specific immunoglobulin G4 antibodies induced by natural exposure to ambrosia pollen in patients with allergy.
    Ostojić V
    Allergy Asthma Proc; 2016; 37(2):115-20. PubMed ID: 26932170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives.
    Purohit A; Niederberger V; Kronqvist M; Horak F; Grönneberg R; Suck R; Weber B; Fiebig H; van Hage M; Pauli G; Valenta R; Cromwell O
    Clin Exp Allergy; 2008 Sep; 38(9):1514-25. PubMed ID: 18564326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.